These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 28978662)

  • 1. Fractalkine induces angiogenic potential in CX3CR1-expressing monocytes.
    Park Y; Lee J; Kwak JY; Noh K; Yim E; Kim HK; Kim YJ; Broxmeyer HE; Kim JA
    J Leukoc Biol; 2018 Jan; 103(1):53-66. PubMed ID: 28978662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1-CX3CL1 interaction.
    Roy-Chowdhury E; Brauns N; Helmke A; Nordlohne J; Bräsen JH; Schmitz J; Volkmann J; Fleig SV; Kusche-Vihrog K; Haller H; von Vietinghoff S
    Cardiovasc Res; 2021 May; 117(6):1510-1522. PubMed ID: 32717023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective roles of the fractalkine/CX3CL1-CX3CR1 interactions in alkali-induced corneal neovascularization through enhanced antiangiogenic factor expression.
    Lu P; Li L; Kuno K; Wu Y; Baba T; Li YY; Zhang X; Mukaida N
    J Immunol; 2008 Mar; 180(6):4283-91. PubMed ID: 18322241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK.
    Green SR; Han KH; Chen Y; Almazan F; Charo IF; Miller YI; Quehenberger O
    J Immunol; 2006 Jun; 176(12):7412-20. PubMed ID: 16751386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CX
    Lee YS; Kim MH; Yi HS; Kim SY; Kim HH; Kim JH; Yeon JE; Byun KS; Byun JS; Jeong WI
    Sci Rep; 2018 Oct; 8(1):15076. PubMed ID: 30305672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
    Amsellem V; Abid S; Poupel L; Parpaleix A; Rodero M; Gary-Bobo G; Latiri M; Dubois-Rande JL; Lipskaia L; Combadiere C; Adnot S
    Am J Respir Cell Mol Biol; 2017 May; 56(5):597-608. PubMed ID: 28125278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokine CX3CL1 (fractalkine) and its receptor CX3CR1: occurrence and potential role in osteoarthritis.
    Wojdasiewicz P; Poniatowski LA; Kotela A; Deszczyński J; Kotela I; Szukiewicz D
    Arch Immunol Ther Exp (Warsz); 2014 Oct; 62(5):395-403. PubMed ID: 24556958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential involvement of the CX3CL1-CX3CR1 axis in bleomycin-induced pulmonary fibrosis via regulation of fibrocyte and M2 macrophage migration.
    Ishida Y; Kimura A; Nosaka M; Kuninaka Y; Hemmi H; Sasaki I; Kaisho T; Mukaida N; Kondo T
    Sci Rep; 2017 Dec; 7(1):16833. PubMed ID: 29203799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CX3CL1-CX3CR1 interaction mediates macrophage-mesothelial cross talk and promotes peritoneal fibrosis.
    Helmke A; Nordlohne J; Balzer MS; Dong L; Rong S; Hiss M; Shushakova N; Haller H; von Vietinghoff S
    Kidney Int; 2019 Jun; 95(6):1405-1417. PubMed ID: 30948201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CX3CR1/CX3CL1 Axis Mediates Platelet-Leukocyte Adhesion to Arterial Endothelium in Younger Patients with a History of Idiopathic Deep Vein Thrombosis.
    Furio E; García-Fuster MJ; Redon J; Marques P; Ortega R; Sanz MJ; Piqueras L
    Thromb Haemost; 2018 Mar; 118(3):562-571. PubMed ID: 29433150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
    Cormican S; Griffin MD
    Front Immunol; 2021; 12():664202. PubMed ID: 34163473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules.
    Butoi ED; Gan AM; Manduteanu I; Stan D; Calin M; Pirvulescu M; Koenen RR; Weber C; Simionescu M
    Biochim Biophys Acta; 2011 Dec; 1813(12):2026-35. PubMed ID: 21888931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis.
    Szukiewicz D
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early activation of the cardiac CX3CL1/CX3CR1 axis delays β-adrenergic-induced heart failure.
    Flamant M; Mougenot N; Balse E; Le Fèvre L; Atassi F; Gautier EL; Le Goff W; Keck M; Nadaud S; Combadière C; Boissonnas A; Pavoine C
    Sci Rep; 2021 Sep; 11(1):17982. PubMed ID: 34504250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
    You JJ; Yang CH; Huang JS; Chen MS; Yang CM
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice.
    Oh DJ; Dursun B; He Z; Lu L; Hoke TS; Ljubanovic D; Faubel S; Edelstein CL
    Am J Physiol Renal Physiol; 2008 Jan; 294(1):F264-71. PubMed ID: 18003857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways.
    Gan AM; Butoi ED; Manea A; Simion V; Stan D; Parvulescu MM; Calin M; Manduteanu I; Simionescu M
    Cell Tissue Res; 2013 Jan; 351(1):161-74. PubMed ID: 23086480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CX3CL1/CX3CR1 Axis Plays a Key Role in Ischemia-Induced Oligodendrocyte Injury via p38MAPK Signaling Pathway.
    Wu XM; Liu Y; Qian ZM; Luo QQ; Ke Y
    Mol Neurobiol; 2016 Aug; 53(6):4010-4018. PubMed ID: 26189830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer.
    Lu X
    Curr Med Chem; 2022; 29(41):6228-6246. PubMed ID: 35770395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.